Sage Partners logo

Sage Partners

North America, Massachusetts, United States, Harwich Port

Description

Sage is your Growth Partner - Growth and Experience matter...because together they unleash Value

Investor Profile

Sage Partners has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (67%)
  • Series C (33%)

Country Focus

  • Hong Kong (33%)
  • United States (33%)
  • China (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Medical
  • Product Research
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sage Partners frequently co-invest with?

Baidu Ventures
Asia, Beijing, China, Beijing
Co-Investments: 1
Deerfield
North America, New York, United States, New York
Co-Investments: 1
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 2
Bold Capital Partners
North America, California, United States, Santa Monica
Co-Investments: 1
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Formic Ventures
North America, California, United States, San Francisco
Co-Investments: 1
CPE
Asia, Beijing, China, Beijing
Co-Investments: 1
B Capital
North America, California, United States, Manhattan Beach
Co-Investments: 1
Eight Roads Ventures
Europe, England, United Kingdom, London
Co-Investments: 2
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 2

What are some of recent deals done by Sage Partners?

AnHeart Therapeutics

Hangzhou, Zhejiang, China

AnHeart Therapeutics is a developer of innovative pharmaceutical products.

Biotechnology
Series BDec 14, 2021
Amount Raised: $61,000,000
Structure Therapeutics

South San Francisco, California, United States

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

BiotechnologyHealth CareMedicalPharmaceuticalProduct Research
Series BOct 20, 2021
Amount Raised: $100,000,000
Insilico Medicine

Hong Kong, Hong Kong Island, Hong Kong

Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.

Artificial Intelligence (AI)BiotechnologyHealth CarePharmaceutical
Series CJun 22, 2021
Amount Raised: $255,000,000